Skip to content

Acupuncture Treatment for Patients Who Develop Arrhythmias in the Post-Operative Cardio-Thoracic Setting

The Feasibility of Acupuncture Treatment in the Post-Operative Cardio-Thoracic Setting for Arrhythmias in Patients Undergoing Open Heart Surgery- A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03525860
Enrollment
47
Registered
2018-05-16
Start date
2018-07-26
Completion date
2019-08-26
Last updated
2021-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture Therapy, Post-Operative Atrial Fibrillation

Brief summary

A feasibility study on the provision of acupuncture treatment in the hospital to 20 patients who have undergone open heart surgery procedures. The acupuncture treatments may begin as early as postoperative Day 2.

Detailed description

Primary Aim • Evaluate the feasibility of providing acupuncture in the hospital setting for 20 patients undergoing open heart surgery and subsequently develop arrhythmias. Secondary Aims • Evaluate the short-term effect of acupuncture including the effects on patient's arrhythmias, stress, anxiety, and pain measured by Electrocardiogram monitoring and Electrocardiography, VAS scores, and WIWI questionnaire for the patient.

Interventions

PROCEDUREAcupuncture

The subject is placed in the selected position (lying down or sitting), based on their comfort level. The areas to be needled are prepped with an alcohol swab. Mandatory standards and safety guidelines for acupuncture will be followed. The acupuncture treatment protocol will be based on Traditional Chinese Medicine (TCM) theory. The TCM treatment strategy is designed to Benefit the Heart, Tonify Heart Qi and Blood, Calm and Sedate Cardiac Excitability and Regulate the Qi. Current literature supports the use of selected acupuncture points as possibly beneficial in regulating the autonomic nervous system, modulating Heart Rate Variability (HRV), relieving chest pain, and reducing arrhythmias. 11 sterile, single use, disposable needles will be placed one by one until all needles are in place. Needles remain in place for additional 20 minutes or so as the patient remains in the selected position .

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who have undergone CABG and/or cardiac valve operations. 2. Patients developing postoperative atrial fibrillation, and documented by ECG prior to acupuncture intervention, and treated with the common anti arrhythmic treatment of the department. 3. Patients moving to the step-down unit on postoperative day 2 or later. 4. Ability to provide informed consent. 5. Ability to speak English and complete all aspects of this trial. 6. At least 18 years of age.

Exclusion criteria

1. Patients with any other cardiac or non-cardiac concomitant procedures. 2. Patients with suspected sternal wound infection and/or with prolonged sternal wound dressing and wound- Vac-system application or open chest wound. 3. Patients with abnormal postoperative track staying in the intensive care unit for any clinical reason or hemodynamic compromise. 4. Patients with platelet count \<50,000 5. Patients in a severe immunocompromised state. 6. Pregnant women. All patients who meet the criteria will have their medical records reviewed to ensure they are not pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Acupuncture treatment in the hospital setting3 days post surgeryThe number of patients that complete acupuncture treatment in the hospital setting for patients having undergone heart surgery.

Secondary

MeasureTime frame
Number of patients with recurrent atrial fibrillation3 consecutive days post-surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026